Psychedelics in psychiatry—keeping the renaissance from going off the rails

DB Yaden, ME Yaden, RR Griffiths - JAMA psychiatry, 2021 - jamanetwork.com
There is a resurgence, some say renaissance, of clinical research on psychedelic
substances after decades of dormancy. Recent studies have produced findings suggesting …

Innovative educational initiatives to train psychodynamic psychiatrists in underserved areas of the world

CA Alfonso, MC Michael, SD Elvira… - Psychiatric …, 2018 - psych.theclinics.com
Although psychoanalysis is not commonly practiced in many areas of the world,
psychodynamic perspectives and constructs enhance the standard of care of the more …

Reported effects of psychedelic use on those with low well-being given various emotional states and social contexts

NL Mason, PC Dolder… - Drug Science, Policy and …, 2020 - journals.sagepub.com
Background It has been suggested that the outcome of the psychedelic experience is
dependent on set and setting. While scientific research into the therapeutic potential of …

[HTML][HTML] Models of psychedelic-assisted psychotherapy: A contemporary assessment and an introduction to EMBARK, a transdiagnostic, trans-drug model

W Brennan, AB Belser - Frontiers in psychology, 2022 - frontiersin.org
The current standard of care in most uses of psychedelic medicines for the treatment of
psychiatric indications includes the provision of a supportive therapeutic context before …

[HTML][HTML] The place of psychotherapy in contemporary psychiatry

S Tavakoli - Iranian journal of psychiatry and behavioral sciences, 2014 - ncbi.nlm.nih.gov
Psychotherapy has long been an essential component of clinical psychiatry and many
young physicians choose to train in psychiatry residency programs in order to acquire …

Studying harms is key to improving psychedelic-assisted therapy—participants call for changes to research landscape

S McNamee, N Devenot, M Buisson - JAMA psychiatry, 2023 - jamanetwork.com
Althoughpsychedelicdrugsgenerallyhavego… profiles, a recent systematic review1
concluded that adverse events in psychedelic trials are poorly defined, not systematically …

Assessing the risk–benefit profile of classical psychedelics: A clinical review of second-wave psychedelic research

D Bender, DJ Hellerstein - Psychopharmacology, 2022 - Springer
Rationale A broad reassessment of the potential benefits of psychedelic drugs has led to the
initiation of multiple major clinical trials in an effort to advance their status to become FDA …

Why psychiatry needs psychedelics and psychedelics need psychiatry

B Sessa - Journal of psychoactive drugs, 2014 - Taylor & Francis
Without researching psychedelic drugs for medical therapy, psychiatry is turning its back on
a group of compounds that could have great potential. Without the validation of the medical …

[HTML][HTML] Co-design of guidance for patient and public involvement in psychedelic research

JB Close, J Bornemann, M Piggin, S Jayacodi… - Frontiers in …, 2021 - frontiersin.org
Within the context of scientific research, patient and public involvement (PPI) is defined as
research performed “with” or “by” patients and members of the public, rather than …

A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses

T Chi, JA Gold - Journal of the Neurological Sciences, 2020 - jns-journal.com
Though there was initial interest in the use of psychedelic drugs for psychiatric treatment,
bad outcomes and subsequent passage of the Substance Act of 1970, which placed …